CONy 2016 Webcasts

Print
PLENARY LECTURES
 
Welcome remarks and invitation to CONy 2017
Victor Oliveira, Portugal
Welcome remarks and invitation to CONy 2017
Marinos Dalakas, Greece
Egas Moniz and his role in 20th century neurology
Victor Oliveira, Portugal
Can the brain be really understood?
Richard Frackowiak, Switzerland
Redefining neurological diseases through epigenetics
Tiago Fleming Outeiro, Germany
Presentation of the CONy "Excellence in Neurology" Award
Sergiu Blumen, Israel and Bernard Brais, Canada
A tribute to Fernando Tomé
Michel Fardeau, France
Beyond the horizon series
Genetics
Guy Rouleau, Canada
Stroke
Lou Caplan, USA
Dementia
George Perry, USA
Neuropathology
Lea Grinberg, USA/Brazil
Epilepsy disease
Michael Sperling, USA
Huntington's disease
Cristina Sampaio, USA
POSTER AWARDS & CLOSING CEREMONY
Amos D. Korczyn, Israel
MULTIPLE SCLEROSIS
SHOULD IMAGING HAVE THE LAST WORD?
Host: Uroš Rot, Slovenia No: Friedemann Paul, Germany Discussion and rebuttals
Debate: My MRI worsened butI didn''t. Should I change my disease-modifying treatment?
Host: Jera Kruja, Albania Yes: Friedemann Paul, Germany No: Jacek Losy, Poland
Discussion and rebuttals
Debate: Is vitamin D a substantial disease modifier in patients with MS?
Host: Jera Kruja, Albania Yes: Friedemann Paul, Germany No: Jacek Losy, Poland
Discussion and rebuttals
Debate: Does the risk of PML associated with certain DMT limit their use and offset their potential efficacy?
Host: Veronica Popescu, Belgium No: Antonio Uccelli, Italy Discussion and rebuttals
Proposition: Patients with radiologically isolated demyelinating syndrome should be considered for MS disease modifying therapy
Host: Xavier Montalban, Spain Yes: David Leppert, Switzerland No: Brian Weinshenker, USA
Discussion and rebuttals
Debate: Should disease-modifying therapies be stopped in patients who have developed secondary progressive MS?
Host: Zsolt Illes, Denmark Yes: Abhijit Chaudhuri, UK No: Jacek Losy, Poland
Discussion and rebuttals
Debate: Anti B cell or non specific anti B+T therapy
Host: Mark Freedman, Canada Pro Anti B+T: Bruno Gran, UK Discussion and rebuttals
Debate: Can we expect long-term clinical improvement through remyelination?
Host: David Leppert, Switzerland Yes: Olaf Stüve, USA No: Abhijit Chaudhuri, UK
Discussion and rebuttals
STROKE
Role of exosomes/miRNA in mediating recovery after stroke and traumatic brain injury
Michael Chopp, USA
Post-stroke cerebral reorganization
Jay P. Mohr, USA
DEMENTIA
Late-Onset Dementias and Alzheimer''s Desease: Can they be prevented
Lefkos T. Middleton, Great Britain
Is AD caused by viral infection?
Ruth Itzhaki, UK
Debate: Is beta-amyloid still a relevant target in AD therapy?
Host: Michael Geschwind, USA
No: Amos Korczyn, Israel
Discussion and rebuttal
Debate: Is imaging of tau the preferable marker of cognitive impairment in AD?
No: Giancarlo Logroscino, Italy
Debate: Dementia with Lewy bodies and PD dementia: Part of one continuum or two distinct entities?
Host: Lefkos T. Middleton, UK Continuum: Laura Parkkinen, UK Distinct entities: Robert Perneczky, UK
Discussion and rebuttals
Debate: Amyotropic laterial sclerosis (ALS) with frontotemporal deficits and FTD - a spectrum or separate entity?
Host: Roger Bullock, UK Spectrum: Lea Grinberg, USA/Brazil Discussion and rebuttals
Debate: Does chronic traumatic encephalopathy (CTE) exist?
Host: Giancarlo Logroscino, Italy Yes: George Perry, USA Discussion and rebuttals
Debate: Is NPH over-diagnosed?
Host: Jaime Kulisevsky, Spain Yes: Michael Geschwind, USA No: Irena Rektorova, Czech Republic
Discussion and rebuttals
Debate: Does corticobasal degeneration ganglionic (CBGD) exist as a clinico-pathological entity?
Host: Ricardo Taipa, Portugal Yes: Néstor Gálvez-Jiménez, USA No: Lea Grinberg, USA/Brazil
Discussion and rebuttals
HEADACHE
Vagus nerve stimulation: Headache and beyond
Stephen Silberstein, USA
EPILEPSY
Proposition: Carbamazepine (CBZ) is an outmoded drug and should never be used as a first-line therapy
Host: João Chaves, Portugal Pro: Martin Brodie, UK Con: Cigdem Ozkara, Turkey
Discussion and rebuttals
Debate: Can we predict with reasonable confidence which patients with idiopathic generalized epilepsy (IGE) will remit?
Yes: Elinor Ben Menachem, Sweden No: Martin Holtkamp, Germany Discussion and rebuttals
Debate: Should we regularly check for autoimmune causes in patients with refractory epilepsy without other obvious causes?
Host: Ilan Blatt, Israel No: William Theodore, USA Discussion and rebuttals
Debate: Can the Wada test be replaced by fMRI and other techniques?
Host: Isabel Santana, Portugal Yes: Michael Sperling, USA No: Cigdem Ozkara, Turkey
Discussion and rebuttals
Debate: Should combination therapy be used after failure of monotherapy with one or two antiepileptic drugs?
Host: Manjari Tripathi, India Yes: Martin Brodie, UK No: Elinor Ben Menachem, Sweden
Discussion and rebuttals
Debate: Should responsive neurostimulation be offered in preference to other forms of neurostimulation when a well defined focus is known?
Host: Michael Sperling, USA Yes: Michael Sperling, USA No: Martin Holtkamp, Germany
Discussion and rebuttals
Debate: Should non-convulsive status epilepticus be treated aggressively?
Host: Ivan Rektor, Czech Republic Yes: Manjari Tripathi, India No: Ilan Blatt, Israel
Discussion and rebuttals
CASE DISCUSSION
Moderators: Francisco Sales, Portugal & Michael Sperling, USA
REHABILITATION
Shifting the paradigm in brain protection and recovery
Dafin Muresanu, Romania
PD/MD
Debate: Is the improvement of MAO-B inhibitors clinically relevant?
Yes: Laszlo Vecsei, Hungary No: Spiros Konitsiotis, Greece Discussion and rebuttals
Debate: Should PD patients with pre-existing impulsive-compulsive behavior (ICB) be actively selected for dopamine agonist treatments?
Host: Heinz Reichmann, Germany Yes: Per Odin, Sweden No: Angel Sesar, Spain
Discussion and rebuttals
Proposition: Therapies targeting alpha-synuclein will be the treatment of choice in PD
Host: Heinz Reichmann, Germany Yes: Dieter H. Meier, USA No: Ruggero G. Fariello, Italy
Discussion and rebuttals
Debate: Prion-like spreading is a relevant theory for neurodegenerative diseases
Host: George Perry, USA No: Amos Korczyn, Israel Discussion and rebuttals
Debate: Do COMT inhibitors have a future?
Host: Alfonso Fasano, Canada Yes: Joaquim Ferreira, Portugal No: Ubaldo Bonuccelli, Italy
Discussion and rebuttals
Debate: Duodopa vs. Apomorphine pumps vs. DBS in advanced PD
Duodopa: Per Odin, Sweden Apomorphine pump: Fabrizio Stocchi, Italy DBS: Ovidiu Bajenaru, Romania
Discussion and rebuttals
Debate: Ultrasound brain lesioning for the treatment of movement disorders?
Yes: Jose Obeso, Spain No: Néstor Gálvez-Jiménez, USA Discussion and rebuttals